792 related articles for article (PubMed ID: 23318473)
1. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
[TBL] [Abstract][Full Text] [Related]
3. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
Kockelmann E; Elger CE; Helmstaedter C
Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
[TBL] [Abstract][Full Text] [Related]
4. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers.
Meador KJ; Loring DW; Vahle VJ; Ray PG; Werz MA; Fessler AJ; Ogrocki P; Schoenberg MR; Miller JM; Kustra RP
Neurology; 2005 Jun; 64(12):2108-14. PubMed ID: 15985582
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
[TBL] [Abstract][Full Text] [Related]
6. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behavioral functioning.
Werz MA; Schoenberg MR; Meador KJ; Loring DW; Ray PG; Kaul-Gupta R; Ogrocki P
Epilepsy Behav; 2006 Feb; 8(1):181-91. PubMed ID: 16377253
[TBL] [Abstract][Full Text] [Related]
7. Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view.
Mills KC; Drazkowski JF; Hammer AE; Caldwell PT; Kustra RP; Blum DE
Epilepsy Res; 2008 Feb; 78(2-3):140-6. PubMed ID: 18155445
[TBL] [Abstract][Full Text] [Related]
8. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Marson AG; Appleton R; Baker GA; Chadwick DW; Doughty J; Eaton B; Gamble C; Jacoby A; Shackley P; Smith DF; Tudur-Smith C; Vanoli A; Williamson PR
Health Technol Assess; 2007 Oct; 11(37):iii-iv, ix-x, 1-134. PubMed ID: 17903391
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
Evans BK; Kustra RP; Hammer AE
Am J Geriatr Pharmacother; 2007 Jun; 5(2):112-9. PubMed ID: 17719513
[TBL] [Abstract][Full Text] [Related]
11. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
[TBL] [Abstract][Full Text] [Related]
12. Cav2.3 (R-Type) Calcium Channels are Critical for Mediating Anticonvulsive and Neuroprotective Properties of Lamotrigine In Vivo.
Dibué-Adjei M; Kamp MA; Alpdogan S; Tevoufouet EE; Neiss WF; Hescheler J; Schneider T
Cell Physiol Biochem; 2017; 44(3):935-947. PubMed ID: 29176325
[TBL] [Abstract][Full Text] [Related]
13. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
15. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
Lhatoo SD; Wong IC; Polizzi G; Sander JW
Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
[TBL] [Abstract][Full Text] [Related]
16. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
Lutz MT; Helmstaedter C
Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
[TBL] [Abstract][Full Text] [Related]
17. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
18. Changes in cognition after introduction or withdrawal of zonisamide versus topiramate in epilepsy patients: A retrospective study using Bayes statistics.
Meschede C; Witt JA; Brömling S; Moskau-Hartmann S; Rademacher M; Surges R; von Wrede R; Helmstaedter C
Epilepsia; 2020 Jul; 61(7):1481-1490. PubMed ID: 32557579
[TBL] [Abstract][Full Text] [Related]
19. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]